India eClinical Solutions Market Outlook to 2028

India e Clinical Solutions Market Overview

The India e Clinical Solutions Market has experienced notable growth, this is reflected by Global e Clinical Solutions Market reaching a valuation of USD 9.1 billion in 2023. This growth is driven primarily by the increasing adoption of cloud-based solutions, advancements in clinical trials, and a growing need for patient data management systems.

The key players in the India e Clinical Solutions Market include Oracle Corporation, Medidata Solutions, Parexel International Corporation, CRF Health, and Bioclinica. These companies have established strong footholds in the market through strategic partnerships, technological innovations, and comprehensive service offerings.

In February 2024, Oracle Life Sciences expanded its global partnership with Obvio Health, a digital clinical trials company. This collaboration focuses on enhancing the capture, integration, and analysis of clinical trial data through the Obvio Go platform, which streams real-time data into Oracle’s Clinical One solution.

The cities dominating the India e Clinical Solutions Market are Mumbai, Bengaluru, and Hyderabad. Mumbai leads due to its advanced healthcare infrastructure and numerous pharmaceutical companies. Bengaluru, known as the IT hub of India, benefits from its strong technology base and numerous clinical research organizations (CROs).

India e Clinical Solutions Market Segmentation

India e Clinical Solutions Market is divided into following segments:

By Product Type: The India e Clinical Solutions Market is segmented by product type into Electronic Data Capture (EDC), Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), and Randomization and Trial Supply Management (RTSM). In 2023, EDC systems held a dominant market share in India due to their widespread adoption in clinical trials for efficient data collection and management.

By Delivery Mode: The India e Clinical Solutions Market is segmented by delivery mode into Web-based, Cloud-based, and Licensed Enterprise (On-premise). In 2023, the Cloud-based segment dominated the market due to its scalability, cost-effectiveness, and ease of access. Cloud-based solutions offer seamless integration and real-time data monitoring, which are crucial for the efficient management of clinical trials.

By Region: The India e Clinical Solutions Market is segmented by region into North, South, East, and West. In 2023, the South region held a dominant market share, driven by the presence of numerous IT companies, CROs, and pharmaceutical giants. The combination of advanced infrastructure, a skilled workforce, and supportive regulatory environments makes the South region a powerhouse in the e Clinical solutions market.

India e Clinical Solutions Market Competitive Landscape

Company

Establishment Year

Headquarters

Oracle Corporation

1977

Redwood Shores, USA

Medidata Solutions

1999

New York, USA

Parexel International Corporation

1982

Boston, USA

CRF Health

2000

Pennsylvania, USA

Bioclinica

1990

Princeton, USA

Medidata Solutions: The renewed collaboration between Medidata Solutions and PPD Clinical Research was officially announced on February 28, 2024. This agreement continues their partnership, which has been in place since 2009, focusing on enhancing clinical trial processes through Medidata's technology, including the True Cast platform powered by AI.

Oracle Corporation: Oracle Cloud Infrastructure (OCI) was selected by India's Ministry of Education in 2023 to modernize the national education technology platform, DIKSHA (Digital Infrastructure for Knowledge Sharing). This collaboration aims to enhance accessibility and reduce IT costs for the platform, which serves approximately 200 million students across 1.48 million schools in India.

India e Clinical Solutions Industry Analysis

India e Clinical Solutions Market Growth Drivers

Increasing Number of Clinical Trials: The growing number of clinical trials in India is a significant growth driver for the e Clinical solutions market. As of 2024, India is home to over 4,000 ongoing clinical trials, reflecting the country's robust clinical research infrastructure and cost-effectiveness. The rise in clinical trials necessitates efficient data management and monitoring solutions, driving the demand for e Clinical solutions.

Adoption of AI and Machine Learning: The integration of AI and machine learning technologies in e Clinical solutions is transforming clinical trial management and data analysis. The Indian government’s Digital India initiative, which promotes the adoption of advanced technologies, has further accelerated this trend.

Growing R&D Activities: Increased R&D activities by biopharma and pharmaceutical companies are driving demand for e Clinical solutions, with a focus on data-driven decision-making in clinical trials. The Indian government has launched the National Policy on R&D and Innovation in the Pharma Med-Tech Sector to foster innovation and transition the sector from cost-based to innovation-based growth.

India e Clinical Solutions Market Challenges

Data Security and Privacy Concerns: Data security and privacy concerns constitute significant challenges to the e Clinical solutions market in India. With the increasing digitization of health records and clinical trial data, the risk of cyber-attacks and data breaches has escalated. In 2023, India witnessed a 37% increase in healthcare data breaches compared to the previous year, according to the Indian Computer Emergency Response Team (CERT-In).

Limited Digital Infrastructure: Despite advancements, the limited digital infrastructure in rural areas of India hampers the widespread adoption of e Clinical solutions. This digital divide restricts the implementation of cloud-based e Clinical solutions, which require reliable internet access. Bridging this gap is essential for the equitable growth of the e Clinical market across the country.

India e Clinical Solutions Market Government Initiatives

National Digital Health Mission (NDHM): The National Digital Health Mission (NDHM), launched in 2021, aims to create a digital health ecosystem in India. As of December 2023, over 50 crore individuals have an ABHA number (unique health ID), and more than 1.5 crore patients have used ABHA-based instant OPD registration services. The ABHA app, with over 50 lakh downloads, enables patients to securely manage their digital health records.

Ayushman Bharat Digital Mission (ABDM): The ABDM was launched on September 27, 2021, not in 2022 as stated. It aims to create an integrated digital health ecosystem in India, facilitating interoperability among various health data systems. The ABDM has an outlay of ₹1,600 crore for a five-year period from 2021-2022 to 2025-2026, aimed at building the necessary infrastructure to support the digital health ecosystem.

India e Clinical Solutions Market Future Outlook

The e Clinical solutions market in India is ready for substantial growth, driven by increased R&D activities, a surge in clinical trials, technological advancements, and supportive government policies. The integration of AI and machine learning in e Clinical platforms will contribute to market growth. Additionally, the rising number of clinical trials in India, driven by the large patient pool and cost-effective operational environment, will further push the market.

Future Market Trends

Growth in Artificial Intelligence and Machine Learning Applications: By 2028, the adoption of artificial intelligence (AI) and machine learning (ML) in e Clinical solutions is expected to transform the clinical trial landscape in India. AI and ML technologies will enhance data analysis, patient recruitment, and monitoring processes, leading to more efficient and accurate clinical trials.

Expansion of Decentralized Clinical Trials: By 2028, more than half of clinical trials in India will adopt decentralized models. This shift will be supported by advancements in digital health technologies, including telemedicine, wearable devices, and mobile health (m Health) applications. According to the Clinical Trials Registry of India (CTRI), the adoption of DCTs will increase significantly, impacting the e Clinical solutions market.
Please Note: It will take 5-7 business days to complete the report upon order confirmation